< Back to companies
BiOMOTUM

BiOMOTUM

Portland, Maine, United States

At BIOMOTUM, we envision a world where all people have access to optimal mobility. Our mission is to optimize human mobility by providing intelligent and intuitive wearable systems, to a wide range of users in the medical and consumer markets. We empower individuals to live healthy and productive lives through the use of our clinically validated products.The ProblemA person’s ability to engage in physical activity, including activities of daily living, is essential to their health, independence, and general wellbeing. According to the CDC, approximately 50 million U.S. adults and children have a physical disability and are unable to engage in some activities of daily living or achieve a sufficient amount of physical activity. Mobility training is critical to improving mobility but there is currently no viable way to deliver a sufficient dose of active gait training.Our SolutionThe BIOMOTUM System addresses the need for individuals to be mobile while being able to engage in sufficient mobility therapy. It allows them to walk independently in the clinic, at home and in the community. Clinical trials have repeatedly demonstrated improvement in mobility outcomes in children with CP. As a smart device, it provides rehabilitation professionals and users activity data to facilitate progression and continued improvement in mobility.Our HistoryBIOMOTUM was founded in Flagstaff, AZ in 2019, by Dr. Zach Lerner, Dr. Ray Browning and Joe Lerner. The founders have been associates for many years. Drs. Lerner and Browning met in 2011 through a shared interest pediatric physical activity as a way to improve chronic diseases and have maintained collaborations since that time.

Share
Shareable draft
Get Involved in BiOMOTUM

Company Info

Founded
2020
Website
www.biomotum.com/

Categories

Fitness or WellnessWearables

Disease Areas

Technologies

Wearable DevicesSmart WearablesSensorsAI/Machine Learning
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of BiOMOTUM?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in BiOMOTUM
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free